Skip to main content
Premium Trial:

Request an Annual Quote

Acacia, CombiMatrix


Acacia subsidiary CombiMatrix has created what is believed to be the first microarray based on the Severe Acute Respiratory Syndrome coronavirus, the company said.

CombiMatrix said the arrays were fabricated “within 48 hours” of publication of the coronavirus genome sequence believed to be responsible for SARS. Researchers at the US Centers for Disease Control and at the Michael Smith Genome Sciences Center in Canada independently announced early this week that they had sequenced the coronavirus genome.


Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.